醒脑静治疗呼吸衰竭并发肺性脑病疗效分析  

Curative effect of Xingnaojing on the treatment of respiratory failure with pulmonary encephalopathy

作　　者：吴利群[1] 任慧琼[1] 张苏扬[1] 鲁进宇[1] 吴珑芝[1] 高往娟 

机构地区：[1]解放军第八五医院干部病房,上海200052

出　　处：《临床军医杂志》2015年第7期726-728,共3页Clinical Journal of Medical Officers

摘　　要：目的观察醒脑静治疗呼吸衰竭并发肺性脑病的临床疗效。方法选取呼吸衰竭并发肺性脑病患者58例,按不同用药方法分为治疗组和对照组。对照组予常规抗感染、解痉平喘、祛痰、无创机械通气等综合治疗,治疗组在此基础上加用醒脑静。结果治疗后治疗组和对照组总有效(显效+好转)率分别为96.7%和82.2%,治疗组优于对照组,但差异无统计学意义(P>0.05)。治疗组显效率明显高于对照组(P<0.05)。治疗后,两组患者的心率(HR)、呼吸频率(RR)、血气指标(Pa O2、Pa CO2、p H)均较治疗前显著改善(P<0.05);与对照组相比,治疗组患者呼吸频率、心率、Pa CO2、p H改善优于对照组(P<0.05)。结论醒脑静治疗呼吸衰竭并发肺性脑病具有良好效果。Objective To observe the clinical curative effect of Xingnaojing on the treatment of respiratory failure with pulmonary encephalopathy. Methods A total of 58 patients were divided into two groups,28 patients in the control group were given routinely by such therapeutic measurea as anti-infection, spasmolysis, eliminating phlegm, non-invasive positive airway pressure mechanical ventilation, etc. And 30 cases in the treating group were treated with Xingnaojing except for the therapeutic measure mentioned a- bove. The course of treatment lasted for 7 days. Results After the treatment, the total effective rate was 96.7% in treatment group and 82.2% in control group（ P 〉 0.05 ） ;the marked effective rate were higher in treatment group than that in the control group （ P 〈 0.05 ）. These index of patients in the treatment group, such as RR, HR, PaO2 , and PaCO2 were improved better in treatment group than that in the control group（ P 〈 0.05 ）. Conclusion It is indicated that Xingnaojing have a significant therapeutic effect on respiratory failure with pulmonary encephalopathy.

关 键 词：醒脑静 中医药治疗 呼吸衰竭 肺性脑病 

分 类 号：R563.8[医药卫生—呼吸系统]